Showing 5,261 - 5,280 results of 5,404 for search '"Thyroid cancer"', query time: 0.24s Refine Results
  1. 5261

    Cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data by Yuan Fang, Xuehong Zhang, Huilin Xu, Stephanie A Smith-Warner, Dongli Xu, Hong Fang, Wang Hong Xu

    Published 2018-12-01
    “…Prevention of female breast and thyroid cancers should be paid attention in Chinese individuals with T2DM.…”
    Get full text
    Article
  2. 5262
  3. 5263

    Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma in a Child: A Case Report by Seung Hee Byun, Sun Kyoung You, Seong Su Kang, Kyung Sook Shin, Jeong Eun Lee

    Published 2020-09-01
    “…However, thyroid ultrasonography revealed characteristic findings of DSPTC, which was confirmed through the postoperative histopathological diagnosis. Although thyroid cancers are rare in the pediatric population, DSPTC should be included in the differential diagnosis of goiter in these patients. …”
    Get full text
    Article
  4. 5264

    Extracervical endoscopic thyroid surgery via Bilateral Axillo-Breast approach (BABA) by Gyan Chand, Goonj Johri

    Published 2020-01-01
    “…We find BABA most suitable for patients who present with larger goitres (≥6cm), toxic glands or low-grade thyroid cancers and are desirous of SET. Here, we describe the surgical technique of BABA, its pros and pitfalls based on our experience.…”
    Get full text
    Article
  5. 5265

    Two Cases of Subsequent Hepatocellular Carcinoma in Immune Checkpoint Inhibitor–Responsive NSCLC: A Case Report by Tia Cheunkarndee, BA, Matthew Z. Guo, BA, Jacqueline E. Birkness-Gartman, MD, Kiyoko Oshima, MD, Cheng Ting Lin, MD, Kristen A. Marrone, MD

    Published 2023-02-01
    “…Although the most common secondary malignancies in patients with lung cancer have historically included colon, rectal, esophageal, and thyroid cancers, we report here two rare cases of new primary hepatocellular carcinomas in patients receiving immune checkpoint inhibitor therapy for NSCLC. …”
    Get full text
    Article
  6. 5266

    Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification by Yanhua Bai, Kennichi Kakudo, Chan Kwon Jung

    Published 2020-12-01
    “…Much progress has been made toward avoiding overdiagnosis and overtreatment of thyroid cancers. The new 2017 World Health Organization (WHO) classification of thyroid neoplasms updated the diagnostic criteria and molecular and genetic characteristics reflecting the biology and behavior of the tumors, and newly introduced the category of borderline malignancy or uncertain malignant potential. …”
    Get full text
    Article
  7. 5267

    Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases by Sevgi Gözdaşoğlu, Ali Pamir, Emel Ünal, İsmail Haluk Gökçora, Ömer Uluoğlu, Koray Ceyhan, Haluk Deda, Erdoğan Işıkman, Gülsan Yavuz, Nurdan Taçyıldız, Ayhan Çavdar

    Published 2016-02-01
    “…A wide variety of SNs have been reported, including leukemias, non-Hodgkin's lymphomas, and solid tumors, specifically breast and thyroid cancers. Herein we report subsequent neoplasms in four patients with HL receiving chemoradiotherapy. …”
    Get full text
    Article
  8. 5268

    Oxyphilic carcinoma of the thyroid gland by Stankov Karmen, Romeo Giovanni

    Published 2003-01-01
    “…Hürthle cell carcinomas (HCC) of the thyroid behave in a more aggressive fashion as compared to other well-differentiated thyroid cancers. Many recent studies have been focused on the further elucidation of pathogenesis and the role of mitochondrial hyperplasia in carcinogenesis of these neoplasms. …”
    Get full text
    Article
  9. 5269
  10. 5270
  11. 5271

    RNA-directed epigenetic silencing of Periostin inhibits cell motility by Nicholas C. Lister, Matthew Clemson, Kevin V. Morris

    Published 2015-01-01
    “…These include breast, ovarian, lung, colon, head and neck, pancreatic, prostate, neuroblastoma and thyroid cancers. It is thought that Periostin plays a major role in the development of metastases owing to its apparent involvement in restructuring of the extracellular matrix to create a microenvironment favouring invasion and metastases, angiogenesis, independent proliferation, avoidance of apoptosis and the ability for cells to re-enter the cell cycle. …”
    Get full text
    Article
  12. 5272

    Dural AVM (dAVM) in Cowden disease by Anthony C. Torres, DO, Parth Upadhyaya, MS-IV, Rajneesh Agrawal, MD

    Published 2017-12-01
    “…Commonly affecting multiple systems, patients typically have an increased risk of breast and thyroid cancers as well as macrocephaly and benign hamartomatous growths. …”
    Get full text
    Article
  13. 5273

    A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma by Mohammadi Masoumeh, Mehdi Hedayati

    Published 2016-11-01
    “…Approximately 5-10% of all thyroid cancers are medullary thyroid carcinomas (MTC). …”
    Get full text
    Article
  14. 5274

    Molecular Functions of Hydrogen Sulfide in Cancer by Rodney E. Shackelford, Islam Z. Mohammad, Andrew T. Meram, David Kim, Fawaz Alotaibi, Stavan Patel, Ghali E. Ghali, Christopher G. Kevil

    Published 2021-09-01
    “…H<sub>2</sub>S-synthesizing enzymes are increased in a variety of human malignancies, including colon, prostate, breast, renal, urothelial, ovarian, oral squamous cell, and thyroid cancers. In cancer, H<sub>2</sub>S promotes tumor growth, cellular and mitochondrial bioenergetics, migration, invasion, angiogenesis, tumor blood flow, metastasis, epithelia–mesenchymal transition, DNA repair, protein sulfhydration, and chemotherapy resistance Additionally, in some malignancies, increased H<sub>2</sub>S-synthesizing enzyme expression correlates with a worse prognosis and a higher tumor stage. …”
    Get full text
    Article
  15. 5275

    Thyroid gland metastasis from breast cancer: A rare case report and literature overview by Inić Zorka, Martinović Aleksandar, Inić Momčilo, Pilčević Dijana, Pupić Gordana

    Published 2018-01-01
    “…The thyroid gland is a rare site for metastatic lesions from non-thyroid cancers. Due to the fact that achieving a diagnosis of thyroid gland metastasis from breast cancer prior to operation is challenging, the diagnosis thereof is mainly based on a pathological biopsy and immunohistochemical staining. …”
    Get full text
    Article
  16. 5276

    Training of Radiofrequency Ablation for Thyroid Nodules in Korea: Current and Future Perspective by Hye Shin Ahn, So Lyung Jung, Jung Hwan Baek, Jin Yong Sung, Ji-hoon Kim

    Published 2023-09-01
    “…Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules and recurrent thyroid cancers. In Korea, RFA for thyroid nodules was first performed in 2002, and a large population study was published in 2008. …”
    Get full text
    Article
  17. 5277
  18. 5278
  19. 5279

    Papel da radioterapia externa no tratamento do carcinoma medular da tiróide. by M A Costa, O Sousa, I Azevedo, C Castro, T Fernandes, E Vieira

    Published 1998-06-01
    “…Medullary carcinoma of the thyroid represents 3 to 10% of all thyroid cancers. Surgery is the main treatment. External beam radiotherapy has a fundamental role in the treatment of residual disease following surgery, in cases of cervical node involvement, and in unresectable tumors. …”
    Get full text
    Article
  20. 5280

    TO THE PROBLEM OF EXPERIMENTAL-MORPHOLOGICAL STUDIES OF RADIATION-INDUCED THYROID DISEASES by Yu. M. Iryanov, G. N. Filimonova

    Published 2016-02-01
    “…Histograms of distribution of thyrocyte nuclear area were dome-shaped in all days of the experimental study except day 2 characterizing follicular and papillary thyroid cancers. The given work is a prospective experimental-morphological study of radiation-induced neuroendocrine cancers…”
    Get full text
    Article